G. Massimo Dondio got his Industrial Chemistry Degree at the University of Milan in 1986. From 1998 he worked for SmithKline Beecham (SB) Italy as Medicinal Chemist and Senior Team Leader of the Delta Opioid Agonists Programme. In 1999 he was appointed Assistant Director Medicinal Chemistry Italy. In 2001 together with other R&D Managers of SB he founded the spin-off named NiKem Research a CRO involved in integrated medicinal chemistry services and was appointed as Director of DMPK and Developability Sciences. Presently is Chief Operating Officer and co-founder of Aphad Srl a CRO for preclinical and clinical pharmacokinetics analytical services. He is the author of more than 40 articles on international journals and of 17 published patent applications. He presented his Medicinal Chemistry and DMPK works at several national and international conferences and he held lectures at several Universities (University of Siena, Pavia, Genova, Pavia, Pisa and Milano).